<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>In this pilot study <z:chebi fb="13" ids="16761">ADP</z:chebi>-ase coated <z:chebi fb="82" ids="53284">polyurethane</z:chebi> (PU) vascular prostheses and noncoated (control) PU vascular prostheses (<z:hpo ids='HP_0000001'>all</z:hpo> vascular prostheses: ID 1.5 mm, length 1.5 cm) were implanted into the carotid artery of the rabbit to test whether <z:chebi fb="13" ids="16761">ADP</z:chebi>-ase might function as an adequate anti-thrombogenic coating </plain></SENT>
<SENT sid="1" pm="."><plain>The prostheses were evaluated after 1 hour (n = 4) and 3 weeks (n = 8) </plain></SENT>
<SENT sid="2" pm="."><plain>After 1 hour, there was extensive accumulation of <z:e sem="disease" ids="C0302148,C0087086" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">thrombus</z:e> on the inner surface of the control PU vascular prostheses, in contrast to the <z:chebi fb="13" ids="16761">ADP</z:chebi>-ase coated prostheses </plain></SENT>
<SENT sid="3" pm="."><plain>At 3 weeks, <z:hpo ids='HP_0000001'>all</z:hpo> control PU vascular prostheses (n = 8) were occluded, whereas only 1 of the 8 ADP-ase coated PU vascular prostheses </plain></SENT>
<SENT sid="4" pm="."><plain>The patient <z:chebi fb="13" ids="16761">ADP</z:chebi>-ase coated PU prostheses showed already extensive endothelial healing </plain></SENT>
<SENT sid="5" pm="."><plain>These results indicate the potential of <z:chebi fb="13" ids="16761">ADP</z:chebi>-ase to function as an effective antithrombogenic coating of small-caliber and microvascular PU prostheses </plain></SENT>
</text></document>